Week Ahead: Stock Rally To Continue On Earnings, Vaccine Roll-Outs; BTC To $50K

 | Feb 14, 2021 08:14AM ET

  • MSCI World Index, S&P 500 registered records on Friday
  • 30-year yield reaches 2%, forecasting rising inflation
  • Oil just shy of $60 level
  • Stocks extended the late-week rebound to hit a fresh record on Friday, boosted by strong earnings growth. All four major US indices—the Dow Jones, S&P 500, NASDAQ and Russell 2000—finished higher ahead of the weekend. Helping buoy investor optimism: the logistics for vaccine distribution in the US improved, after President Joseph Biden announced his administration had purchased an additional 200 million COVID-19 inoculations.

    The MSCI World Equity Index climbed 0.4% on Friday, to a record for the global equity index, advancing for the tenth straight day in a row, gaining 5.9%, in its longest winning streak in years. Risk-on sentiment will likely continue lifting markets into the coming week, even as US inflation and jobs data showed growth had stalled.

    Ongoing jobless claims continue to remain substantially higher than pre-pandemic levels which only served to reinforce the case and increase bets for additional stimulus along with the possibility of rising inflation. With no new obstacles in the week ahead on the economic calendar, stock bulls should find little resistance to their slow but dogged charge upward to new ground.

    h2 US Equities Score New Records; Inflation Signals Escalate/h2

    The S&P 500 scored yet another all-time high on Friday, this time with attitude, ahead of the three-day Presidents' Day holiday weekend, with a solid candle no less, demonstrating trader confidence at being locked into the most expensive equities in history. The SPX gained 1.2% for the week while the Dow rose 1% and the tech-heavy NASDAQ added 1.7% over the same period.

    Energy significantly outperformed, (+1.5%), reflecting the rally in oil.

    However, not every stock was a winning bet. Online travel company Expedia (NASDAQ:EXPE) released results that showed it had another disappointing quarter. Revenue plummeted 67%, slipping below the psychological billion-dollar level to just $920M—its fourth year-over-year drop in a row.